John D. Diekman, PhD's Bio
John D. Diekman, PhD, is a founder and managing partner of 5AM Ventures. Prior to founding 5AM, he was a founder and managing director of Bay City Capital, a life sciences investment firm. Previously, he was chair and CEO of Affymetrix Inc., where he still serves as a director. Diekman currently serves as board chair of Ambrx and Envoy Therapeutics and as a member of the boards of Igenica, Ingenuity Systems, Marcadia, PhaseRx and Wildcat Discovery.
He is a special advisor to the Singapore Economic Development Board, a trustee of Princeton University and a former trustee of the California Institute of Technology and Scripps Research Institute, where he served as chairman. He is an honorary officer in the Order of Australia.
Diekman received a BA in chemistry from Princeton University and a PhD in Chemistry from Stanford University. He holds an honorary Doctor of Laws from Monash University.